BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 6978327)

  • 1. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M; Fritzler MJ; Blüthner M
    Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G; Lührmann R; Metz B; Peter HH
    Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical evaluation of antibodies against soluble nuclear antigens].
    Sánchez-Ibarrola A
    Allergol Immunopathol (Madr); 1983; 11(3):201-6. PubMed ID: 6605081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in collagen diseases].
    Meyer O
    Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)].
    Nasonova VA; Poverennyĭ AM; Nasonov EL; Lekakh IV; Tachmuradova MD
    Ter Arkh; 1985; 57(5):94-8. PubMed ID: 3161200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies against soluble nuclear antigens ENA, RNP and Sm: comparison of different detection methods in collagen diseases (author's transl)].
    Rivero S; Sánchez G
    Rev Med Chil; 1981 Aug; 109(8):711-6. PubMed ID: 6177024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of double immunodiffusion method (ENA-1 test) for detecting anti RNP and/or Sm antibodies].
    Miyawaki S; Sakamoto K; Onodera H
    Rinsho Byori; 1985 Sep; 33(9):1025-30. PubMed ID: 3935834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.